We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clarifies Supply Chain Exemptions to Speed Delivery of Approved Naloxone Products
FDA Clarifies Supply Chain Exemptions to Speed Delivery of Approved Naloxone Products
In another move to address the opioid crisis, the FDA has issued a guidance — effective immediately — that clarifies some supply chain requirements for the overdose treatment Naloxone (naloxone hydrochloride) to help make the treatment more accessible.